Multiple drug resistant tuberculosis.
作者信息
Drobniewski F A, Yates M D
出版信息
J Clin Pathol. 1997 Feb;50(2):89-90. doi: 10.1136/jcp.50.2.89.
Abstract
摘要
相似文献
1
Multiple drug resistant tuberculosis.多重耐药结核病
J Clin Pathol. 1997 Feb;50(2):89-90. doi: 10.1136/jcp.50.2.89.
2
The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?多重耐药的威胁：结核病是否永远无法治疗或无法控制？
Lancet. 1999 Mar 20;353(9157):998-9. doi: 10.1016/S0140-6736(99)01439-7.
3
Multidrug resistant tuberculosis.耐多药结核病
Indian Pediatr. 1998 Aug;35(8):715-8.
4
Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6.1994 - 1996年英国耐抗生素结核病的数据库研究。
BMJ. 1999 Feb 20;318(7182):497-8. doi: 10.1136/bmj.318.7182.497.
5
Epidemiology, control and treatment of multidrug-resistant tuberculosis.耐多药结核病的流行病学、控制与治疗
Drugs. 1996;52 Suppl 2:103-7; discussion 107-8. doi: 10.2165/00003495-199600522-00021.
6
Challenges and Outlooks in Multi-drug Resistant Tuberculosis.耐多药结核病的挑战与展望
Arch Bronconeumol. 2017 Aug;53(8):417-418. doi: 10.1016/j.arbres.2017.01.018. Epub 2017 Mar 14.
7
Molecular analysis of drug resistant TB.耐多药结核病的分子分析
Thorax. 2002 Jun;57(6):562-3. doi: 10.1136/thorax.57.6.562.
8
Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.耐多药结核病：标准化治疗还是个体化治疗？这个问题已经有答案了。
Expert Rev Respir Med. 2010 Apr;4(2):143-6. doi: 10.1586/ers.10.6.
9
Multidrug resistant tuberculosis.耐多药结核病
BMJ. 2015 Feb 26;350:h882. doi: 10.1136/bmj.h882.
10
Breakpoints and drug exposure are inevitably closely linked.断点与药物暴露不可避免地紧密相连。
Antimicrob Agents Chemother. 2015 Feb;59(2):1384. doi: 10.1128/AAC.04485-14.
引用本文的文献
1
Antibiotic resistance: a current perspective.抗生素耐药性：当前视角
Br J Clin Pharmacol. 1999 Aug;48(2):109-24. doi: 10.1046/j.1365-2125.1999.00997.x.
本文引用的文献
1
Molecular diagnosis, detection of drug resistance and epidemiology of tuberculosis.
Br J Hosp Med. 1996;56(5):204-8.
2
Improved outcomes for patients with multidrug-resistant tuberculosis.耐多药结核病患者的治疗效果得到改善。
Clin Infect Dis. 1995 Nov;21(5):1238-44. doi: 10.1093/clinids/21.5.1238.
3
4
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.171例耐异烟肼和利福平肺结核患者的治疗
N Engl J Med. 1993 Feb 25;328(8):527-32. doi: 10.1056/NEJM199302253280802.
5
Drug resistance is not the principal barrier to effective control of tuberculosis in Zambia.
J Infect Dis. 1994 May;169(5):1180-1. doi: 10.1093/infdis/169.5.1180.
6
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods.纽约市结核病的传播。通过DNA指纹识别技术和传统流行病学方法进行的分析。
N Engl J Med. 1994 Jun 16;330(24):1710-6. doi: 10.1056/NEJM199406163302403.
7
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.多重耐药对结核病短程化疗未来的影响：一项分子研究。
Lancet. 1994 Jul 30;344(8918):293-8. doi: 10.1016/s0140-6736(94)91338-2.
8
Tuberculosis in New York City--turning the tide.纽约市的结核病——扭转局势
N Engl J Med. 1995 Jul 27;333(4):229-33. doi: 10.1056/NEJM199507273330406.
9
Multidrug-resistant tuberculosis in patients without HIV infection.无HIV感染患者的耐多药结核病
N Engl J Med. 1995 Oct 5;333(14):907-11. doi: 10.1056/NEJM199510053331404.
10
Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991.1982 - 1991年英格兰和威尔士结核分枝杆菌初始分离株中的耐药性
Commun Dis Rep CDR Rev. 1993 Dec 3;3(13):R175-9.
Zotero 插件